Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 13210 | 853 | 27.9 | 54% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 607 | 3 | BACULOVIRUS//NUCLEOPOLYHEDROVIRUS//CYTOTECHNOLOGY | 14212 |
| 3451 | 2 | HUMAN HUMAN HYBRIDOMA//IMMUNOGLOBULIN PRODUCTION STIMULATING FACTOR//HYBRIDOMA | 1523 |
| 13210 | 1 | MONOCLONAL ANTIBODY HUMAN//HYBRIDOMA//INVITRO IMMUNIZATION | 853 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | MONOCLONAL ANTIBODY HUMAN | authKW | 176221 | 1% | 62% | 8 |
| 2 | HYBRIDOMA | journal | 123169 | 10% | 4% | 85 |
| 3 | INVITRO IMMUNIZATION | authKW | 74569 | 1% | 42% | 5 |
| 4 | PERIPHERAL B LYMPHOCYTE | authKW | 71592 | 0% | 100% | 2 |
| 5 | HUMAN MONOCLONAL ANTIBODY | authKW | 70196 | 2% | 10% | 19 |
| 6 | GENIE GENET CELLULAIRE | address | 64431 | 0% | 60% | 3 |
| 7 | HETEROHYBRIDOMA | authKW | 64425 | 1% | 30% | 6 |
| 8 | JOURNAL OF IMMUNOLOGICAL METHODS | journal | 59005 | 15% | 1% | 126 |
| 9 | HYBRIDOMA HUMAN | authKW | 47727 | 0% | 67% | 2 |
| 10 | IN VITRO IMMUNIZATION | authKW | 43212 | 1% | 15% | 8 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Immunology | 11091 | 54% | 0% | 463 |
| 2 | Biochemical Research Methods | 6806 | 30% | 0% | 256 |
| 3 | Biotechnology & Applied Microbiology | 869 | 15% | 0% | 125 |
| 4 | CYTOLOGY & HISTOLOGY | 555 | 1% | 0% | 11 |
| 5 | Oncology | 276 | 11% | 0% | 96 |
| 6 | Biology | 124 | 4% | 0% | 35 |
| 7 | BIOLOGY, MISCELLANEOUS | 89 | 0% | 0% | 2 |
| 8 | Medicine, Research & Experimental | 80 | 5% | 0% | 41 |
| 9 | Virology | 69 | 3% | 0% | 23 |
| 10 | Medical Laboratory Technology | 59 | 2% | 0% | 14 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | GENIE GENET CELLULAIRE | 64431 | 0% | 60% | 3 |
| 2 | 30 MERIDIAN RD | 35796 | 0% | 100% | 1 |
| 3 | CLIFMAR ASSOCIATES LTD | 35796 | 0% | 100% | 1 |
| 4 | CLIN IMMUNOL GENET ENGN BIOTECHNOL | 35796 | 0% | 100% | 1 |
| 5 | CLIN MICROSCOPY MED TECHNOL GEN | 35796 | 0% | 100% | 1 |
| 6 | DANA FARBER CANC IMMUNOPHYSIOL | 35796 | 0% | 100% | 1 |
| 7 | HARVARD MIT HUMAN SCI TECHNOL | 35796 | 0% | 100% | 1 |
| 8 | HETEROHYBRIDOMA | 35796 | 0% | 100% | 1 |
| 9 | INNOVAT ANTIBODY ENGN | 35796 | 0% | 100% | 1 |
| 10 | MED SERVBONE MARROW TRANSPLANTAT UNIT | 35796 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | HYBRIDOMA | 123169 | 10% | 4% | 85 |
| 2 | JOURNAL OF IMMUNOLOGICAL METHODS | 59005 | 15% | 1% | 126 |
| 3 | DEVELOPMENTS IN BIOLOGICALS | 22287 | 1% | 7% | 9 |
| 4 | IMMUNOLOGY LETTERS | 1848 | 2% | 0% | 17 |
| 5 | SOMATIC CELL GENETICS | 1395 | 0% | 1% | 3 |
| 6 | HYBRIDOMA AND HYBRIDOMICS | 1309 | 0% | 1% | 3 |
| 7 | INTERFERON Y BIOTECNOLOGIA | 1277 | 0% | 4% | 1 |
| 8 | LOUVAIN MEDICAL | 1232 | 0% | 3% | 1 |
| 9 | FOLIA BIOLOGICA | 1231 | 1% | 0% | 7 |
| 10 | METHODS IN ENZYMOLOGY | 1126 | 3% | 0% | 23 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | JAMES, K , BELL, GT , (1987) HUMAN MONOCLONAL-ANTIBODY PRODUCTION - CURRENT STATUS AND FUTURE-PROSPECTS.JOURNAL OF IMMUNOLOGICAL METHODS. VOL. 100. ISSUE 1-2. P. 5-40 | 107 | 68% | 153 |
| 2 | LINDL, T , (1996) DEVELOPMENT OF HUMAN MONOCLONAL ANTIBODIES: A REVIEW.CYTOTECHNOLOGY. VOL. 21. ISSUE 3. P. 183-193 | 53 | 79% | 2 |
| 3 | OHARE, MJ , YIU, CY , (1987) HUMAN MONOCLONAL-ANTIBODIES AS CELLULAR AND MOLECULAR PROBES - A REVIEW.MOLECULAR AND CELLULAR PROBES. VOL. 1. ISSUE 1. P. 33-54 | 70 | 57% | 8 |
| 4 | THOMPSON, KM , (1988) HUMAN MONOCLONAL-ANTIBODIES.IMMUNOLOGY TODAY. VOL. 9. ISSUE 4. P. 113-117 | 35 | 80% | 41 |
| 5 | DESSAIN, SK , ADEKAR, SP , BERRY, JD , (2008) EXPLORING THE NATIVE HUMAN ANTIBODY REPERTOIRE TO CREATE ANTIVIRAL THERAPEUTICS.HUMAN ANTIBODY THERAPEUTICS FOR VIRAL DISEASE. VOL. 317. ISSUE . P. 155-183 | 46 | 29% | 12 |
| 6 | SAMOILOVICH, SR , DUGAN, CB , MACARIO, AJL , (1987) HYBRIDOMA TECHNOLOGY - NEW DEVELOPMENTS OF PRACTICAL INTEREST.JOURNAL OF IMMUNOLOGICAL METHODS. VOL. 101. ISSUE 2. P. 153-170 | 47 | 52% | 32 |
| 7 | GROVES, DJ , MORRIS, BA , (2000) VETERINARY SOURCES OF NONRODENT MONOCLONAL ANTIBODIES: INTERSPECIFIC AND INTRASPECIFIC HYBRIDOMAS.HYBRIDOMA. VOL. 19. ISSUE 3. P. 201 -214 | 41 | 34% | 20 |
| 8 | RODER, JC , COLE, SPC , KOZBOR, D , (1986) THE EBV HYBRIDOMA TECHNIQUE.METHODS IN ENZYMOLOGY. VOL. 121. ISSUE . P. 140 -167 | 41 | 62% | 31 |
| 9 | COLE, SPC , CAMPLING, BG , ATLAW, T , KOZBOR, D , RODER, JC , (1984) HUMAN MONOCLONAL-ANTIBODIES.MOLECULAR AND CELLULAR BIOCHEMISTRY. VOL. 62. ISSUE 2. P. 109-120 | 48 | 60% | 26 |
| 10 | UCHIYAMA, K , SAITO, H , TOKUHISA, T , IMAI, K , TANIGUCHI, M , (1987) HIGH-FREQUENCY OF LOSS OF HUMAN KAPPA-LIGHT CHAIN EXPRESSION IN MOUSE-HUMAN HETEROHYBRIDOMAS.HYBRIDOMA. VOL. 6. ISSUE 6. P. 645-654 | 24 | 92% | 12 |
Classes with closest relation at Level 1 |